Cytotoxicity of peroxisome proliferator-activated receptor α and γ agonists in renal proximal tubular cell lines

被引:11
作者
Giral, Hector [1 ]
Villa-Bellosta, Ricardo [1 ]
Catalan, Julia [1 ]
Sorribas, Victor [1 ]
机构
[1] Univ Zaragoza, Lab Mol Toxicol, E-50013 Zaragoza, Spain
关键词
PPAR; peroxisome proliferator; WY14643; clofibrate; ciglitazone; pioglitazone; proximal tubule; cytotoxicity; OK cells; LLC-PK1; MCT; kidney;
D O I
10.1016/j.tiv.2007.03.021
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Fibrates and thiazolidinediones are agonists of peroxisome proliferator-activated receptors (PPAR) a and gamma, pharmacologically designed to control dyslipidemia and insulin resistance, respectively. Several works have reported the toxicity of some agonists in a number of tissues. In this work we have analyzed the toxicity of two PPAR alpha (WY14643 and clofibrate) and two PPAR gamma (pioglitazone and ciglitazone) agonists, using three different renal proximal tubular cell lines: Opossum OK, pig LLC-PK1, and murine MCT. Cell death was determined by the activity of intracellular lactate dehydrogenase. WY14643 and ciglitazone increased cell death with LC50 values of 92-1241 mu M and 8.6-14.8 mu M, respectively, depending on the cell line. Clofibrate and pioglitazone were, however, non-cytotoxic even at concentrations of 10 and 100 higher than the corresponding EC50, which suggests that cell death is independent of PPAR activation. Discrimination between apoptosis or necrosis was analyzed by light microscopy and stress fiber morphology, double staining with acridine orange and ethidium bromide, binding of annexin V, caspase-3 activity, and DNA laddering. With these methods, no signs of apoptosis were observed, which suggests a direct necrosis of the compounds on these renal proximal tubular cell lines. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1066 / 1076
页数:11
相关论文
共 42 条
[1]   OXIDANT-INDUCED ALTERATIONS IN GLUCOSE AND PHOSPHATE-TRANSPORT IN LLC-PK1 CELLS - MECHANISMS OF INJURY [J].
ANDREOLI, SP ;
MCATEER, JA ;
SEIFERT, SA ;
KEMPSON, SA .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (03) :F377-F384
[2]   Stimulation of proximal tubular cell apoptosis by albumin-bound fatty acids mediated by peroxisome proliferator activated receptor-γ [J].
Arici, M ;
Chana, R ;
Lewington, A ;
Brown, J ;
Brunskill, NJ .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (01) :17-27
[3]   Cardioprotective properties of fibrates - Which fibrate, which patients, what mechanism? [J].
Barter, PJ ;
Rye, KA .
CIRCULATION, 2006, 113 (12) :1553-1555
[4]   The mechanisms of action of PPARs [J].
Berger, J ;
Moller, DE .
ANNUAL REVIEW OF MEDICINE, 2002, 53 :409-435
[5]   Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor γ in vascular smooth muscle cells [J].
Bruemmer, D ;
Yin, F ;
Liu, J ;
Berger, JP ;
Sakai, T ;
Blaschke, F ;
Fleck, E ;
Van Herle, AJ ;
Forman, BM ;
Law, RE .
CIRCULATION RESEARCH, 2003, 93 (04) :E38-E47
[6]  
Brunton L., 2005, Goodman and Gilman's The Pharmacological Basis of Therapeutics, VEleventh
[7]   Protective effect of peroxisome proliferator activated receptor gamma agonists on diabetic and non-diabetic renal diseases [J].
Chung, BH ;
Lim, SW ;
Ahn, KO ;
Sugawara, A ;
Ito, S ;
Choi, BS ;
Kim, YS ;
Bang, BK ;
Yang, CW .
NEPHROLOGY, 2005, 10 :S40-S43
[8]   Sensitive endpoints for evaluating cadmium-induced acute toxicity in LLC-PK1 cells [J].
Gennari, A ;
Cortese, E ;
Boveri, M ;
Casado, J ;
Prieto, P .
TOXICOLOGY, 2003, 183 (1-3) :211-220
[9]   Antineoplastic effects of peroxisome proliferator-activated receptor γ agonists [J].
Grommes, C ;
Landreth, GE ;
Heneka, MT .
LANCET ONCOLOGY, 2004, 5 (07) :419-429
[10]   Peroxisome proliferator-activated receptors (PPARs): Novel therapeutic targets in renal disease [J].
Guan, YF ;
Breyer, MD .
KIDNEY INTERNATIONAL, 2001, 60 (01) :14-30